{"References": [{"title": "Fibroblast growth factor 21 as a potential therapeutic agent for metabolic diseases", "authors": "Kharitonenkov, A., Shanafelt, A. B.", "journal": "Expert Opinion on Therapeutic Targets", "year": "2009", "volumes": "13", "first page": "671", "last page": "684", "DOI": "10.1517/14728220903041972"}, {"title": "FGF21 and the metabolic syndrome", "authors": "Fisher, F. M., Maratos-Flier, E.", "journal": "Journal of Clinical Investigation", "year": "2016", "volumes": "126", "first page": "385", "last page": "392", "DOI": "10.1172/JCI86083"}, {"title": "Fibroblast growth factor 21: a novel metabolic regulator", "authors": "Kharitonenkov, A., Larsen, P.", "journal": "Diabetes, Obesity and Metabolism", "year": "2011", "volumes": "13", "first page": "1", "last page": "10", "DOI": "10.1111/j.1463-1326.2010.01318.x"}, {"title": "FGF21 as a novel metabolic regulator", "authors": "Potthoff, M. J., Kliewer, S. A., Mangelsdorf, D. J.", "journal": "Journal of Molecular Endocrinology", "year": "2012", "volumes": "48", "first page": "R1", "last page": "R10", "DOI": "10.1530/JME-11-0145"}, {"title": "Fibroblast growth factor 21: a novel therapeutic target for obesity-related diseases", "authors": "Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y. S., Lindberg, R. A.", "journal": "Endocrinology", "year": "2009", "volumes": "150", "first page": "762", "last page": "770", "DOI": "10.1210/en.2008-0989"}, {"title": "FGF21: a central metabolic regulator", "authors": "Kharitonenkov, A., Adams, A. C.", "journal": "BioDrugs", "year": "2014", "volumes": "28", "first page": "15", "last page": "22", "DOI": "10.1007/s40259-013-0066-7"}, {"title": "Fibroblast growth factor 21: a novel regulator of energy metabolism", "authors": "Inagaki, T., Lin, V. Y., Goetz, R., Mohammadi, M., Mangelsdorf, D. J., Kliewer, S. A.", "journal": "Hepatology", "year": "2008", "volumes": "47", "first page": "1417", "last page": "1424", "DOI": "10.1002/hep.22164"}, {"title": "FGF21 and its role in metabolic diseases: from discovery to therapies", "authors": "Gimeno, R. E., Moller, D. E.", "journal": "Trends in Endocrinology & Metabolism", "year": "2014", "volumes": "25", "first page": "303", "last page": "311", "DOI": "10.1016/j.tem.2014.03.003"}, {"title": "Fibroblast growth factor 21: a novel therapeutic target for obesity and fatty liver disease", "authors": "Gaich, G., Chien, J. Y., Fu, H., Glass, L. C., Deeg, M. A., Holland, W. L., Kharitonenkov, A., Bumol, T. F., Schilske, H. K., Moller, D. E.", "journal": "Clinical Pharmacology & Therapeutics", "year": "2013", "volumes": "94", "first page": "366", "last page": "372", "DOI": "10.1038/clpt.2013.120"}, {"title": "FGF21: a novel metabolic regulator", "authors": "Kharitonenkov, A., Shanafelt, A. B.", "journal": "Journal of Clinical Investigation", "year": "2008", "volumes": "118", "first page": "10", "last page": "19", "DOI": "10.1172/JCI36271"}]}